Respiratory physician Lutz Beckert considers chronic obstructive pulmonary disease management, including the prevention of COPD, the importance of smoking cessation and pulmonary rehabilitation, and the lifesaving potential of addressing treatable traits. He also discusses the logic of inhaler therapy, moving from single therapy to dual and triple therapy when indicated, as well as other aspects of management
Helping travellers decide when to receive Japanese encephalitis vaccine
+Practice
Travel Medicine
Helping travellers decide when to receive Japanese encephalitis vaccine
Saturday 15 February 2025, 12:20 AM

Countries in Asia and the western Pacific in which Japanese encephalitis virus has been identified [Image: CDC]
Japanese encephalitis is a rare disease in travellers, but for those who do become symptomatic, it carries significant mortality and morbidity risk. This article discusses a new online tool to support decisions around vaccination
This Practice article has been endorsed by the RNZCGP and has been approved for up to 0.5 credits for continuing professional development purposes (2 , Educate small, BACK panel - grey
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.
References
Lau CL, Mills DJ, Mayfield H, et al. A decision support tool for risk-benefit analysis of Japanese encephalitis vaccine in travellers. J Travel Med 2023;30(7):taad113.